Researchers from Icahn School of Medicine at Mount Sinai, New York City, have received a $1.1 million grant from the World Trade Center Health Program to study the risks of kidney and heart disease among ground zero first responders and volunteers exposed to the toxic dust-cloud created by the disaster 13 years ago, according to a news release.
Responders and volunteers were exposed to varying levels of air filled with cement dust, smoke, glass fibers and heavy metals during at ground zero. Mount Sinai researchers believe high levels of exposure to the dust cloud may cause inflammation that can result in the development of chronic kidney disease and cardiovascular damage.
Our research will determine the frequency and degree of kidney dysfunction in these patients, and examine the relationship between kidney and cardiovascular diseases among first responders to the tragedy at ground zero and volunteers who were there, Mary Ann McLaughlin, MD, MPH, medical director of the cardiac health program at Mount Sinai Hospital and the studys principal investigator, said in the release.
Our long-term goal is to identify and minimize the risks for these conditions among individuals exposed to the inhaled toxins.
A clinical center of excellence at Mount Sinai is a treatment and monitoring program for emergency responders, recovery workers, residents and area workers affected by the terrorist attacks in New York City in 2001. The program identifies health problems needing timely treatment, monitors the development of symptoms, and analyzes data on the effects of 9/11. Located at Mount Sinai and several other clinics in the tri-state area, the Clinical Centers of Excellence and Data Centers are the result of the James Zadroga 9/11 Health and Compensation Act, which provides $4.3 billion in federal funding to serve the health needs of the men and women affected by the World Trace Center attacks.